Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 2
1993 4
1994 3
1995 1
1996 3
1997 2
1999 2
2000 4
2001 6
2002 3
2003 6
2004 5
2005 5
2006 4
2007 12
2008 6
2009 8
2010 7
2011 6
2012 13
2013 16
2014 12
2015 10
2016 9
2017 14
2018 18
2019 22
2020 18
2021 21
2022 14
2023 7
2024 17
2025 15
2026 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

265 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean golding jp[Author] (49 results)?
Cost-effectiveness of tirzepatide versus semaglutide for patients with obesity or overweight in the US: evidence from the SURMOUNT-5 head-to-head phase-3 trial.
Johansson E, Wilding JPH, Upadhyay N, van Hest N, Kirk M, Spaepen E, Zimner-Rapuch S, Annemans L, Bays H. Johansson E, et al. Among authors: wilding jph. J Med Econ. 2026 Dec;29(1):1258-1278. doi: 10.1080/13696998.2026.2646078. Epub 2026 Apr 21. J Med Econ. 2026. PMID: 42012820 Free article. Clinical Trial.
Variation in the Commissioning of Semaglutide for the Treatment of Obesity and Overweight Across England: Results of Three Freedom of Information-Based Mapping Exercises Across the 42 Integrated Care Boards of England.
de Bray A, Schnitzer H, Mahase E, Singh P, Andrews R, McGowan BM, Le Brocq S, Wilding JPH, Flint SW, Hazlehurst JM. de Bray A, et al. Among authors: wilding jph. Clin Obes. 2026 Feb;16(1):e70044. doi: 10.1111/cob.70044. Epub 2025 Sep 11. Clin Obes. 2026. PMID: 40931685 Free PMC article.
Outcomes of Different Lifestyle Approaches in a Multicentre, Open-Label, Parallel-Group, Randomised Controlled Trial of the Effectiveness of Integrating a Pragmatic Pathway for Prescribing Liraglutide 3.0 mg in Weight Management Services (STRIVE Study).
Al-Najim W, Dehestani B, Al-Humadi AW, Bodicoat DH, Papamargaritis D, Lean M, McGowan B, Webb DR, Wilding JP, Davies MJ, le Roux CW. Al-Najim W, et al. Among authors: wilding jp. Metabolites. 2025 Jun 13;15(6):398. doi: 10.3390/metabo15060398. Metabolites. 2025. PMID: 40559422 Free PMC article.
Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity.
Garvey WT, Blüher M, Osorto Contreras CK, Davies MJ, Winning Lehmann E, Pietiläinen KH, Rubino D, Sbraccia P, Wadden T, Zeuthen N, Wilding JPH; REDEFINE 1 Study Group. Garvey WT, et al. Among authors: wilding jph. N Engl J Med. 2025 Aug 14;393(7):635-647. doi: 10.1056/NEJMoa2502081. Epub 2025 Jun 22. N Engl J Med. 2025. PMID: 40544433 Clinical Trial.
Defective lymphatic vasculature in obesity.
Zhu J, Wilding JPH, Hu J. Zhu J, et al. Among authors: wilding jph. Obes Rev. 2025 Aug;26(8):e13922. doi: 10.1111/obr.13922. Epub 2025 Mar 27. Obes Rev. 2025. PMID: 40150810 Free PMC article. Review.
265 results